Altered activities of antioxidant enzymes in patients with metabolic syndrome

Obesity Facts

Volumn 6, Issue 1, 2013, Pages 39-47

  Vávrová, Lucie ^a   Kodydková, Jana ^a   Zeman, Miroslav ^a   Dušejovská, Magdaléna ^a   Macášek, Jaroslav ^a   Staňková, Barbora ^a   Tvrzická, Eva ^a   Žák, Aleš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antioxidant enzymes; Conjugated dienes; Metabolic syndrome; Reduced glutathione

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; BILIRUBIN; CALCIUM CHANNEL BLOCKING AGENT; CATALASE; CONJUGATED DIENES IN LOW DENSITY LIPOPROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE REDUCTASE; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; ENZYME; HIGH DENSITY LIPOPROTEIN; PEROXY RADICAL; SUPEROXIDE DISMUTASE; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; ANTIOXIDANT ACTIVITY; BODY MASS; CAUCASIAN; MIDDLE AGED; SMOKING; WAIST CIRCUMFERENCE;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATALASE; ENZYMES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 84874010239     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000348569     Document Type: Article

References (39)

1. Grundy SM: Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Metabol 2007; 92: 399-404
2. Roberts CK, Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci 2009; 84: 705-712
3. Duracková Z: Some current insights into oxidative stress. Physiol Res 2010; 59: 459-469
4. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84
5. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, 4th ed. Oxford, Oxford University Press, 2008
6. Surh YJ: Transcriptional regulation of cellular antioxidant defense mechanism; in Surh YJ, Packer L (eds): Oxidative Stress, Inflammation and Health. Boca Raton, CRC Press, 2005, pp21-40
7. Soran H, Younis NN, Charlton-Menys V, Durrington P: Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 2009; 20: 265-274
8. Harris ED: Regulation of antioxidant enzymes. FASEB J 1992; 6: 2675-2683
9. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome - A new worldwide definition. Lancet 2005; 366: 1059- 1062
10. Kodydková J, Vávrová L, Zeman M, Jirák R, Macásek J, Stanková B, Tvrzická E, Zák A: Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem 2009; 42: 1368-1374
11. Griffith OW: Glutathione and glutathione disulphide; in Bergemeyer HU (ed): Methods of Enzymatic Analysis, Weinheim, VCH 1985, pp 521-529
12. Wieland H, Seidel D: A simple specific method for precipitation of low density lipoproteins. J Lipid Res 1983; 24: 904-909
13. Vogeser M, König D, Frey I, Predel HG, Parhofer KG, Berg A: Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons. Clin Biochem 2007; 40: 964-968
14. Roth E, Manhart N, Wessner B: Assessing the antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care 2004; 7: 161-168
15. Yamagishi SI, Edelstein D, Du XL, Brownlee M: Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001; 50: 1491-1494
16. Paravicini TM, Touyz RM: NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care 2008; 31:S170-S180
17. Nordberg J, Arnér ES: Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001; 31: 1287-1312
18. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761
19. Dimitrijevic-Sreckovic V, Colak E, Djordjevic P, Gostiljac D, Sreckovic B, Popovic S, Canovic F, Ilic M, Obrenovic R, Vukcevic V, Nikolic D, Nisic T, Milic G, Pejcic G: Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome. Clin Chem Lab Med 2007; 45: 1140-1144
20. Cardona F, Túnez I, Tasset I, Montilla P, Collantes E, Tinahones FJ: Fat overload aggravates oxidative stress in patients with the metabolic syndrome. Eur J Clin Invest 2008; 38: 510-515
21. Cardona F, Tunez I, Tasset I, Murri M, Tinahones FJ: Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridaemia with or without the metabolic syndrome. Clin Biochem 2008; 41: 701-705
22. Amstad P, Peskin A, Shah G, Mirault ME, Moret R, Zbinden I, Cerutti P: The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 1991; 30: 9305-9313
23. Low FM, Hampton MB, Winterbourn CC: Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid Redox Signal 2008; 10: 1621-30
24. Kirkman HN, Galiano S, Gaetani GF: The function of catalase-bound NADPH. J Biol Chem 1987; 262: 660-666
25. Viroonudomphol D, Pongpaew P, Tungtrongchitr R, Phonrat B, Supawan V, Vudhivai N, Schelp FP: Erythrocyte antioxidant enzymes and blood pressure in relation to overweight and obese Thai in Bangkok. Southeast Asian J Trop Med Public Health 2000; 31: 325-334
26. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP: Relationship between oxidative stress and essential hypertension. Hypertens Res 2007; 30: 1159-1167
27. Shin MJ, Park E: Contribution of insulin resistance to reduced antioxidant enzymes and vitamins in nonobese Korean children. Clin Chim Acta 2006; 365: 200-205
28. Nandeesha H, Sathiyapriya V, Bobby Z, Pavithran P, Agrawal A, Selvaraj N: Altered oxidant-antioxidant status in non-obese men with moderate essential hypertension. Indian J Med Sci 2007; 61: 326-331
29. Chistiakov DA, Zotova EV, Savost'anov KV, Bursa TR, Galeev IV, Strokov IA, Nosikov VV: The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab 2006; 32: 63-68
30. Bougoulia M, Triantos A, Kolioakos G: Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors. Hormones (Athens) 2006; 5: 192-199
31. Paşaoǧlu H, Muhtaroǧlu S, Güneş M, Utaş C. The role of the oxidative state of glutathione and glutathionerelated enzymes in anemia of hemodialysis patients. Clin Biochem1996: 29: 567-72
32. Garin MC, Kalix B, Morabia A, James RW: Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 2264-2269
33. Rizos E, Tambaki AP, Gazi I, Tselepis AD, Elisaf M: Lipoprotein- associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 203-209
34. Novak F, Vavrova L, Kodydkova J, Novak F Sr, Hynkova M, Zak A, Novakova O: Decreased paraoxonase activity in critically ill patients with sepsis. Clin Exp Med 2010; 10: 21-25
35. Rosenblat M, Aviram M: Paraoxonases role in the prevention of cardiovascular diseases. Biofactors 2009; 35: 98-104
36. Güzel S, Seven A, Satman I, Burçak G: Comparison of oxidative stress indicators in plasma of recent-onset and long-term type 1 diabetic patients. J Toxicol Environ Health A 2000; 59: 7-14
37. Zák A, Tvrzická E, Vecka M, Jáchymová M, Duffková L, Stanková B, Vávrová L, Kodydková J, Zeman M: Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men. Tohoku J Exp Med 2007; 212: 359-371
38. Zeman M, Zák A, Vecka M, Tvrzická E, Romaniv S, Konárková M: Treatment of hypertriglyceridaemia with fenofibrate, fatty acid composition of plasma and LDL, and their relations to parameters of lipoperoxidation of LDL. Ann N Y Acad Sci 2002; 967: 336-341
39. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr: Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008; 299: 2287-2293